Exceptional breakdown of METHODIQ's competitve positioning. The bit about using 1 million+ images to train vision models shows they're not just copying Hims but actually bringing somthing new to the table with proprietary data moats. I worked in healthtech for a while and the weekly check-in loop with real-time tracking could be huge for patient adherence, which is honestly where most telemedicine falls apart.
Exceptional breakdown of METHODIQ's competitve positioning. The bit about using 1 million+ images to train vision models shows they're not just copying Hims but actually bringing somthing new to the table with proprietary data moats. I worked in healthtech for a while and the weekly check-in loop with real-time tracking could be huge for patient adherence, which is honestly where most telemedicine falls apart.
Thanks for your insight!